Literature DB >> 24033661

Humoral hypercalcemia caused by uterine corpus carcinosarcoma consisting of squamous cell carcinoma in its epithelial component.

Shiro Takamatsu1, Noriomi Matsumura, Tsukasa Baba, Masaki Mandai, Yoshiki Mikami, Ikuo Konishi.   

Abstract

Humoral hypercalcemia of malignancy (HHM) is a paraneoplastic syndrome primarily caused by a tumor-producing parathyroid hormone-related protein (PTH-rP). We describe the first reported case of a uterine carcinosarcoma causing HHM. A 70-year-old patient was transferred to our hospital for a uterine tumor accompanied by impaired consciousness. The laboratory tests indicated anemia, malnutrition, elevated serum calcium and elevated PTH-rP. Emergency surgery, including abdominal hysterectomy and bilateral salpingo-oophorectomy, was performed due to uncontrollable uterine bleeding. The pathological diagnosis was carcinosarcoma consisting of pure squamous cell carcinoma in its epithelial component. Postoperatively, chemotherapy with paclitaxel and carboplatin was performed. The patient had recurrent tumors at the para-aortic lymph nodes 11 months after the initial surgery and underwent a pelvic and para-aortic lymphadenectomy, which removed all of the recurrent tumors.
© 2013 The Authors. Journal of Obstetrics and Gynaecology Research © 2013 Japan Society of Obstetrics and Gynecology.

Entities:  

Keywords:  carcinosarcoma; hypercalcemia; parathyroid hormone-related protein; squamous cell carcinoma; uterine neoplasms

Mesh:

Substances:

Year:  2013        PMID: 24033661     DOI: 10.1111/jog.12136

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  2 in total

Review 1.  Humoral Hypercalcemia in Uterine Cancers: A Case Report and Literature Review.

Authors:  Vijeyaluxmy Motilal Nehru; Gwenalyn Garcia; Juan Ding; Fanyi Kong; Qun Dai
Journal:  Am J Case Rep       Date:  2017-01-06

2.  Hypercalcemia of Malignancy: Simultaneous Elevation in Parathyroid Hormone-Related Peptide and 1,25 Dihydroxyvitamin D in Sarcoma.

Authors:  Dong Won Kim; Ann Miller; Andrew Li; Naomi Hardy; Kristi D Silver
Journal:  AACE Clin Case Rep       Date:  2021-01-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.